BMC Medical Co., Ltd. (301367.SZ) has a MoatMap StockRank of 39/100 based on Quality (67/100), Value (35/100), and Momentum (24/100) factor scores. The current signal is HOLD. BMC Medical is a leading Chinese manufacturer of sleep apnea devices with strong domestic market share and growing export potential. However, its export-heavy model faces structural headwinds as Western nations push for medical supply chain localization and impose tariffs.
BMC Medical Co., Ltd. is a global developer and manufacturer of home respiratory care devices, specializing in CPAP machines, ventilators, and patient interfaces for sleep apnea and chronic respiratory diseases. The company holds a leading market share in China and a strong international presence, competing directly with global giants through cost-effective, high-quality respiratory solutions. It is a highly competitive, R&D-driven player in the global sleep medicine market.
| Price | $6.18 |
| Market Cap | $829M |
| P/E (TTM) | 28.84 |
| Price/Book | 1.81 |
| Return on Equity | 6.6% |
| Return on Invested Capital | 8.7% |
| Debt/Equity | 1.60 |
| Gross Margin | 53.2% |
| Operating Margin | 18.8% |
| Revenue Growth | 16.5% |
| Dividend Yield | 1.5% |
| Free Cash Flow | $703K |
BMC Medical Co., Ltd. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (China).